Medical Market Report

Global NGS Based Diagnostics Market By Type (DNA Sequencing, RNA Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, Other), By Application (Hospitals, Clinics, Academics/Research Institutions), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135426
  • 16-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Global NGS Based Diagnostics Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global ngs based diagnostics Market is segmented on the basis of Type, Application, and geography.
    The worldwide market for Global NGS Based Diagnostics Market is expected to grow at a CAGR of roughly x.x% over the next ten years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    NGS Based Diagnostics Market Scope:

    By type, the market is segmented into DNA Sequencing, RNA Sequencing, Whole Genome Sequencing, Whole Exome Sequencing, and Other. By Application, the market is divided into Hospitals, Clinics, and Academics/Research Institutions.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Janssen, Roche, Qiagen, ThermoFisher Scientific, Oxford Gene Technology, Illumina, Pacific Biosciences, Paradigm Diagnostics, Innogene Kalbiotech, Admera Health, AITbiotech, Centogene, Phalanx Biotech Group, and iGenomX.

    Key Market Segments

    Type

    DNA Sequencing

    RNA Sequencing

    Whole Genome Sequencing

    Whole Exome Sequencing

    Other

    Application

    Hospitals

    Clinics

    Academics/Research Institutions

    Key Market Players included in the report:

    Janssen

    Roche

    Qiagen

    ThermoFisher Scientific

    Oxford Gene Technology

    Illumina

    Pacific Biosciences

    Paradigm Diagnostics

    Innogene Kalbiotech

    Admera Health

    AITbiotech

    Centogene

    Phalanx Biotech Group

    iGenomX

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Global NGS Based Diagnostics Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Global NGS Based Diagnostics Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Global NGS Based Diagnostics Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global NGS Based Diagnostics Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Global NGS Based Diagnostics Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Global NGS Based Diagnostics Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Global NGS Based Diagnostics Market sub-markets, depending on key regions (various vital states).
    To analyze Global NGS Based Diagnostics Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Global NGS Based Diagnostics Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Global NGS Based Diagnostics Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Global NGS Based Diagnostics Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global NGS Based Diagnostics Market Overview
    

    3.1. Global NGS Based Diagnostics Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Manufacturer Intensity Map4. Global NGS Based Diagnostics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global NGS Based Diagnostics Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. DNA Sequencing
    

      4.4. RNA Sequencing
    

      4.5. Whole Genome Sequencing
    

      4.6. Whole Exome Sequencing
    

      4.7. Other5. Global NGS Based Diagnostics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global NGS Based Diagnostics Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospitals
    

      5.4. Clinics
    

      5.5. Academics/Research Institutions6. Global NGS Based Diagnostics Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Global NGS Based Diagnostics Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Global NGS Based Diagnostics Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Global NGS Based Diagnostics Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia
    

      6.4. Latin America
    

        6.4.1. Latin America Global NGS Based Diagnostics Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Global NGS Based Diagnostics Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global NGS Based Diagnostics Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Janssen
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3. 3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Roche
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4. 4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Qiagen
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5. 5. Key Strategies and Developments  7.6. ThermoFisher Scientific
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Oxford Gene Technology
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Illumina
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Pacific Biosciences
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7. 10.Paradigm Diagnostics
    

        7. 10.1. Company Overview
    
    7. 10.2. Financial Highlights
    
    7. 10.3. Product Portfolio
    
    7. 10.4. SWOT Analysis
    
    7. 10.5. Key Strategies and Developments  7. 11. Innogene Kalbiotech
    

        7. 11.1. Company Overview
    
    7. 11.2. Financial Highlights
    
    7. 11.3. Product Portfolio
    
    7. 11.4. SWOT Analysis
    
    7. 11.5. Key Strategies and Developments  7. 12. Admera Health
    

        7. 12.1. Company Overview
    
    7. 12.2. Financial Highlights
    
    7. 12.3. Product Portfolio
    
    7. 12.4. SWOT Analysis
    
    7. 12.5. Key Strategies and Developments  7. 13. AITbiotech
    

        7. 13.1. Company Overview
    
    7. 13.2. Financial Highlights
    
    7. 13.3. Product Portfolio
    
    7. 13.4. SWOT Analysis
    
    7. 13.5. Key Strategies and Developments  7. 14. Centogene
    

        7. 14.1. Company Overview
    
    7. 14.2. Financial Highlights
    
    7. 14.3. Product Portfolio
    
    7. 14.4. SWOT Analysis
    
    7. 14.5. Key Strategies and Developments  7. 15. Phalanx Biotech Group
    

        7. 15.1. Company Overview
    
    7. 15.2. Financial Highlights
    
    7. 15.3. Product Portfolio
    
    7. 15.4. SWOT Analysis
    
    7. 15.5. Key Strategies and Developments  7. 16. iGenomX
    

        7. 16.1. Company Overview
    
    7. 16.2. Financial Highlights
    
    7. 16.3. Product Portfolio
    
    7. 16.4. SWOT Analysis
    
    7. 16.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10.Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.